Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer

Peter Kozuch, Michael L. Grossbard, Atis Barzdins, Miguel Araneo, Abigail Robin, David Frager, Peter Homel, Jennifer Marino, Paola Degregorio, H. W. Bruckner

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences